S
Savendra
About Savendra
Data last updated:
Savendra is a Managing Director at Aindri Nidhi Limited (since 2017), Director at Aindri Sahayata Foundation (since 2021) and Director at Vit Pharmaceuticals Private Limited (since 2021). The companies operate in Financial Services, Non-Profit Organizations and Chemicals. The largest current company by reported revenue is Aindri Nidhi Limited at ₹7.2 Lakh (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 26 Jul 2017 | 2017 | ₹7.2 Lakh (FY 2021) | Active | |
| Director | 06 Dec 2021 | 2021 | Active | ||
| Director | 16 Sep 2021 | 2021 | Active |
Board colleagues of Savendra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akhilesh Kumar | 09387226 | Aindri Nidhi Limited , Aindri Sahayata Foundation | Director |
| Brijbhushan Gond | 08633149 | Aindri Nidhi Limited , Aindri Sahayata Foundation | Director |
| Brijbiharee Gond | 09322235 | Vit Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Savendra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Savendra
Savendra currently holds 3 directorships: Aindri Nidhi Limited (Managing Director, since 26 Jul 2017, revenue ₹7.2 Lakh (FY 2021)); Aindri Sahayata Foundation (Director, since 06 Dec 2021); Vit Pharmaceuticals Private Limited (Director, since 16 Sep 2021).
Savendra was first appointed on 26 Jul 2017 as Managing Director at Aindri Nidhi Limited. The most recent appointment on record is 06 Dec 2021 at Aindri Sahayata Foundation.
The current boards of Savendra's companies include Akhilesh Kumar (Aindri Nidhi Limited), Brijbhushan Gond (Aindri Nidhi Limited), Brijbiharee Gond (Vit Pharmaceuticals Private Limited).